cha biotech rpe

Samyang Group, a diversified conglomerate, has long focused on the chemicals and foodstuffs sectors. While adding to its existing chemicals bus...

Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...

South Korea’s chemicals giant LG Chem Ltd. announced on Oct. 18 that it will acquire AVEO Pharmaceuticals Inc., a Nasdaq-listed US biotech fir...

CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...

South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...

South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...

Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...

SD Biosensor Inc., South Korea’s leading in-vitro diagnostics company, has signed an agreement to supply its COVID-19 self-test kits and other...

The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...

Harim Co., South Korea’s top poultry processing company, is seeking to acquire Genofocus Inc., a Kosdaq-listed industrial and pharmaceutical e...

WASHINGTON DC – SK Group, South Korea’s second-largest conglomerate, said on Wednesday it will build its first memory chip packaging fac...

South Korean investment firm SK Square Co. has sold all of its shares in Korean biotech NanoEntek Inc., a 28.4% stake, for 58 billion won ($44.3 mil...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...

South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...

South Korea’s medical center operator CHA Healthcare Co. said on Monday it has acquired the management rights of Fertility Specialists of West...

South Korea’s biotechnology firms – public and private alike –  are facing increasingly negative financial conditions. T...

South Korean direct-to-consumer (DTC) genetic testing companies are rushing to the veterinary diagnostics market where they see greater potential gr...

  LianBio, a Nasdaq-listed biotechnology company, has joined hands with MediRama Co., a South Korean clinical development firm, to help promis...

Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...

South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...

The incoming Yoon Suk-yeol administration will lend extra support to the startup ecosystem – biotech and artificial intelligence firms in part...

FutureChem Co., a South Korean radiopharmaceutical company, is seeking the US Food and Drug Administration’s approval for clinical tests of it...

Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...

Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...

South Korea’s first generation biotech firm Medipost Co. will sell a 30% stake to a private equity consortium, the company announced after W...

South Korea’s biotechnology startup Voronoi Inc. scrapped its plan to go public this month. The new drug developer announced Wednesday it...

South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...

South Korea’s biotechnology startup Voronoi Inc. plans an initial public offering in March to raise up to 130 billion won ($108.4 million).Vor...